This company listing is no longer active
METabolic EXplorer (METEX) Stock Overview
A biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
METEX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
METabolic EXplorer S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.12 |
| 52 Week High | €0.98 |
| 52 Week Low | €0.05 |
| Beta | 1.07 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -58.14% |
| 3 Year Change | -97.67% |
| 5 Year Change | -90.52% |
| Change since IPO | -98.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| METEX | FR Chemicals | FR Market | |
|---|---|---|---|
| 7D | 0% | -3.3% | -1.8% |
| 1Y | -58.1% | 8.4% | 2.0% |
Return vs Industry: METEX underperformed the French Chemicals industry which returned 12.9% over the past year.
Return vs Market: METEX underperformed the French Market which returned 1.8% over the past year.
Price Volatility
| METEX volatility | |
|---|---|
| METEX Average Weekly Movement | 0% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in FR Market | 10.8% |
| 10% least volatile stocks in FR Market | 2.5% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine METEX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 450 | Benjamin Gonzalez | www.metabolic-explorer.com |
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials.
METabolic EXplorer S.A. Fundamentals Summary
| METEX fundamental statistics | |
|---|---|
| Market cap | €6.16m |
| Earnings (TTM) | -€49.34m |
| Revenue (TTM) | €168.17m |
Is METEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| METEX income statement (TTM) | |
|---|---|
| Revenue | €168.17m |
| Cost of Revenue | €174.73m |
| Gross Profit | -€6.56m |
| Other Expenses | €42.78m |
| Earnings | -€49.34m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.97 |
| Gross Margin | -3.90% |
| Net Profit Margin | -29.34% |
| Debt/Equity Ratio | 122.3% |
How did METEX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/09 02:12 |
| End of Day Share Price | 2024/10/09 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
METabolic EXplorer S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arsene Guekam | CIC Market Solutions (ESN) |
| Nicolas Royot | Portzamparc BNP Paribas |
| Christophe Dombu Youta | Portzamparc BNP Paribas |